1. DSpace-CRIS @ ANLIS
  2. Instituto Nacional de Enfermedades Infecciosas
  3. Publicaciones INEI
Por favor, use este identificador para citar o enlazar este ítem: http://sgc.anlis.gob.ar/handle/123456789/2220
Campo DC Valor Lengua/Idioma
dc.contributor.authorKurbatova, E Ves
dc.contributor.authorCavanaugh, J Ses
dc.contributor.authorShah, N Ses
dc.contributor.authorWright, A.es
dc.contributor.authorKim, HeeJines
dc.contributor.authorMetchock, Bes
dc.contributor.authorVan Deun, A.es
dc.contributor.authorBarrera, Lucíaes
dc.contributor.authorBoulahbal, Fes
dc.contributor.authorRichter, Ees
dc.contributor.authorMartín-Casabona, Nes
dc.contributor.authorArias, Fes
dc.contributor.authorZemanova, Ies
dc.contributor.authorDrobniewski, Fes
dc.contributor.authorSantos Silva, Aes
dc.contributor.authorCoulter, Ces
dc.contributor.authorLumb, Res
dc.contributor.authorCegielski, J Pes
dc.date.accessioned2021-01-21T18:29:39Z-
dc.date.available2021-01-21T18:29:39Z-
dc.date.issued2012-
dc.identifier.issn1815-7920-
dc.identifier.urihttp://sgc.anlis.gob.ar/handle/123456789/2220-
dc.descriptionFil: Kurbatova, E V. Centers for Disease Control and Prevention, Atlanta, Georgia; Estados Unidos.es
dc.descriptionFil: Cavanaugh, J S. Centers for Disease Control and Prevention, Atlanta, Georgia; Estados Unidos.es
dc.descriptionFil: Shah, N S. Division of General Internal Medicine, Albert Einstein College of Medicine, Bronx, New York; Estados Unidos.es
dc.descriptionFil: Wright, A. World Health Organization, Geneva; Suiza.es
dc.descriptionFil: Kim, HeeJin. Korean Institute of Tuberculosis, Seoul; Korea.es
dc.descriptionFil: Metchock, B. Centers for Disease Control and Prevention, Atlanta, Georgia; Estados Unidos.es
dc.descriptionFil: Van Deun, A. Institute of Tropical Medicine, Antwerp; Belgica.es
dc.descriptionFil: Barrera, Lucia. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.es
dc.descriptionFil: Boulahbal, F. Institut Pasteur d’Algérie, Alger; Argelia.es
dc.descriptionFil: Richter, E. National Reference Center for Mycobacteria, Borstel; Alemania.es
dc.descriptionFil: Martín-Casabona, N. Hospital Universitaris Vall d’Hebron, Barcelona; España.es
dc.descriptionFil: Arias, F. Institute of Public Health of Chile, Providencia Santiago, Santiago; Chile.es
dc.descriptionFil: Zemanova, I. National Institute of Public Health, Scrobarova; Chequia.es
dc.descriptionFil: Drobniewski, F. Health Protection Agency, London; Reino Unido.es
dc.descriptionFil: Santos Silva, A. National Institute of Health, Porto; Portugal.es
dc.descriptionFil: Coulter, C. Queensland Mycobacterium Reference Laboratory, Brisbane, Queensland; Australia.es
dc.descriptionFil: Lumb, R. Institute of Medical and Veterinary Science, Adelaide, South Australia; Australia.es
dc.descriptionFil: Cegielski, J P. Centers for Disease Control and Prevention, Atlanta, Georgia; Estados Unidos.es
dc.description.abstractBased on data from 14 Supranational Tuberculosis (TB) Reference Laboratories worldwide, the proportion of rifampicin (RMP) resistant isolates that were isoniazid (INH) susceptible by phenotypic drug susceptibility testing varied widely (0.5-11.6%). RMP-resistant isolates that were INH-susceptible had significantly lower rates of resistance to other first- and second-line anti-tuberculosis drugs (except rifabutin) compared to multidrug-resistant isolates. RMP resistance is not always a good proxy for a presumptive diagnosis of multidrug-resistant TB, which has implications for use of molecular assays that identify only RMP resistance-associated DNA mutations.es
dc.formatpdf-
dc.language.isoenes
dc.publisherInternational Union Against Tuberculosis and Lung Diseasees
dc.relation.ispartofThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Diseasees
dc.rightsClosed Access-
dc.sourceInternational Journal of Tuberculosis and Lung Disease 2012 ;16(3):355-7.-
dc.subjectMycobacterium tuberculosises
dc.subjectTuberculosises
dc.subjectResistencia a Medicamentoses
dc.titleRifampicin-resistant Mycobacterium tuberculosis: susceptibility to isoniazid and other anti-tuberculosis drugses
dc.typeArtículoes
dc.identifier.doi10.5588/ijtld.11.0542-
anlis.essnrd1-
item.languageiso639-1en-
item.openairetypeArtículo-
item.grantfulltextopen-
item.cerifentitytypePublications-
item.fulltextWith Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
Aparece en las colecciones: Publicaciones INEI
Ficheros en este ítem:
Fichero Descripción Tamaño Formato
10.5588_ijtld.11.0542.pdfArtículo en inglés120.9 kBAdobe PDFVisualizar/Abrir
Mostrar el registro sencillo del ítem

Visualizaciones de página(s)

76
comprobado en 16-jun-2025

Descarga(s)

11
comprobado en 16-jun-2025

Google ScholarTM

Consultar

Altmetric

Altmetric


Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.